Lenalidomide also inhibits MALT1-mediated BCL10 cleavage and suppresses NFκB activity in non-GCB DLBCL cell lines (22); however, the involvement of CK1α in these activities has not been investigated. This evidence concerns the gene BCL10 and diffuse large B-cell lymphoma.